Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses.
The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s marketplace technology to help hospitals, pharmacies and clinics access essential medications at savings of more than 50%, according to a Dec. 4 news release shared with Becker’s.
The marketplace also includes tools to identify savings opportunities, measure financial impact and integrate pricing insights into clinical decision-making.
The companies said the expanded collaboration reflects a shared commitment to transparency and affordability in the drug supply chain.
